antibody drugs
Samsung Biologics expands antibody production deal with Bristol Myers Squibb for $242 million
Anika Sharma
Samsung Biologics, a leading biopharmaceutical contract manufacturing organization, has strengthened its partnership with Bristol Myers Squibb (BMS) by securing a ...
